Random

FDA

Many Clinical Trials Often Absent From Journals

Many Clinical Trials Often Absent From Journals

FDA Approves OxyContin For Extremely Sick Kids

Issues Related to Healthcare FDA

FDA Approves OxyContin For Extremely Sick Kids

FDA Needs to Go Further in Curbing E-Cigarette Use by Teens

E-Cigarette News

FDA Needs to Go Further in Curbing E-Cigarette Use by Teens

Study Questions Safety of Silicone Breast Implants; FDA Disputes Findings

Study Questions Safety of Silicone Breast Implants

Issues Related to Healthcare News FDA Quick Hits

Quick Hits: FDA Approval for New Antibiotic, ADHD Med & More

FDA Drug Recalls and Warnings: Compounded Semaglutide and Tirzepatide

FDA Drug Recalls and Warnings: Recalls for Compounded Semaglutide and Tirzepatide, Wegovy; Facility Warning Letters

Pressure Building on FDA For More Rigorous Sunscreen Testing

Pressure Building on FDA for More Rigorous Sunscreen Testing

FDA: Consumer Drug Ads ‘Unreliable’ & ‘Potentially Misleading’

FDA: Consumer Drug Ads ‘Unreliable’ & ‘Potentially Misleading’

FDA side effect update, Depo Provera

FDA SIDE EFFECTS UPDATE: Depo Provera and Brain Tumors, Veozah Boxed Warning And More

J&J Risperdal

Healthy Skeptic new

J&J Walk of Shame

Suzanne B. Robotti

FDA Safe Use Initiative: Safe Only When Taken as Directed

FDA Safe Use Initiative: Safe Only When Taken as Directed

Will The FDA Kill Off E-Cigarettes? That's Not the Question

E-Cigarette News

Will The FDA Kill Off E-Cigarettes? That’s Not the Question

Suzanne B. Robotti

NSAID Side Effects Lead To Stronger FDA Warnings

NSAID Side Effects Lead To Stronger FDA Warnings

Hot Flashes = Hot Market For Noven

Healthy Skeptic new

Hot Flashes = Hot Market For Noven

Suzanne B. Robotti

Finally! FDA Approves Rule To Regulate E-Cigarettes

E-Cigarette News

Finally! FDA Approves Rule To Regulate E-Cigarettes

FDA Looking Into New Concern With E-Cigs: Seizures

E-Cigarette News

FDA Looking Into New Concern With E-Cigs: Seizures

FDA Drug Recalls and Warnings: Illegal GLP-1 Sales and Misleading Marketing by Novo Nordisk and Eli Lilly

FDA Drug Recalls and Warnings: Illegal GLP-1 Sales and Misleading Marketing by Novo Nordisk and Eli Lilly

FDA Gives Singulair the Thumbs Down for OTC

FDA Gives Singulair the Thumbs Down for OTC

MedShadow's Top 10 Stories of 2018 (FDA)

MedShadow Articles

MedShadow’s Top 10 Stories of 2018 (FDA)

man putting in eye drops, eye drop recall

FDA Drug Recalls and Warnings: Eye Drops Recall; Clinical Trials Violations

Load More

x

x